Cargando…
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum
Autores principales: | Yan, Libin, Ding, Beichen, Liu, Haoran, Zhang, Yangjun, Zeng, Jin, Hu, Junhui, Yao, Weimin, Yu, Gan, An, Ruihua, Chen, Zhiqiang, Ye, Zhangqun, Xing, Jinchun, Xiao, Kefeng, Wu, Lily, Xu, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690931/ https://www.ncbi.nlm.nih.gov/pubmed/34987655 http://dx.doi.org/10.7150/thno.68810 |
Ejemplares similares
-
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma
por: Yan, Libin, et al.
Publicado: (2019) -
Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum
por: Liu, Haoran, et al.
Publicado: (2022) -
Erratum: MicroRNA-125b Down-Regulation Mediates Endometrial Cancer Invasion by Targeting ERBB2
por: Shang, Chao, et al.
Publicado: (2020) -
HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395
por: Sun, Guoliang, et al.
Publicado: (2020) -
Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395
por: Sun, Guoliang, et al.
Publicado: (2023)